Company Filing History:
6 out of 30 
2 out of 6 Years Active: 2012-2018
Title: Ulla Impola: Innovator in Stem Cell Research
Introduction
Ulla Impola is a prominent inventor based in Helsinki, Finland. She has made significant contributions to the field of stem cell research, holding a total of six patents. Her work focuses on the glycosylation of stem cells and the methods to evaluate and control cell populations.
Latest Patents
One of her latest patents is titled "Method for evaluating cell populations." This invention describes specific sialylated structures present on human stem cells and cell populations derived from them. The invention is particularly directed towards methods to control the status of stem cells by observing changes in sialylation. It also addresses the control of potential contaminations of biological materials and the reagents and methods used in connection with the cells to avoid alterations of cell glycosylation by contaminating materials. Furthermore, the invention introduces novel stem cells with specifically altered glycosylation.
Another significant patent is "Carbohydrate profile compositions from human cells and methods for analysis and modification thereof." This invention outlines methods for producing novel compositions of glycans, or glycomes, from human multipotent stem cells. It also includes methods for modifying and analyzing these glycomes and the modified glycomes. Additionally, the invention is directed towards stem cells that carry the modified glycomes on their surfaces.
Career Highlights
Ulla has worked with notable companies such as Glykos Finland Oy and the Finnish Red Cross Blood Service. Her experience in these organizations has contributed to her expertise in stem cell research and innovation.
Collaborations
Ulla has collaborated with several professionals in her field, including Jari Natunen and Tero Satomaa. These collaborations have further enhanced her research and development efforts.
Conclusion
Ulla Impola is a trailblazer in the field of stem cell research, with a focus on glycosylation and cell population evaluation. Her innovative patents and career achievements highlight her significant contributions to science and technology.